Join us online on 28 September 2023 from 16:00 – 18:00 CEST for the EXIMIOUS Symposium “Risk assessment of mixed exposures: particles, carcinogens, and EU policies”.

Bispebjerg Hospital at Region Hovedstaden (REGIONH) in Denmark is our next partner in the spotlight. It is a large community hospital with many different specialties, complex patient cases and a diverse patient group.

Researchers at Vall d’Hebron Research Institute tell us about their cohort studies related to park surveillance and the health risks associated with it.

Dr. Manosij Ghosh and Dr. Evangel Kummari present some of EXIMIOUS’ most recent results at EPICOH 2023 and the 2023 SOT Annual Meeting.

Today our partner in the spotlight is Biogenity – a Contract Research Organisation (CRO) focusing on making bioinformatics, Machine- and Deep Learning accessible.

More than 80 participants joined the fourth EXIMIOUS Symposium. Did you miss it? Read about it here and watch the full recording.

Join us online on 26 January 2023 at 16:00 – 18:00 CET for the EXIMIOUS Symposium “Do chemicals penetrate human skin? How skin absorption of chemicals contributes to human exposure”.

The European Human Exposome Network (EHEN) third newsletter announces the launch of its Toolbox and introduces the health impact of exposome reaserach and the diseases studied by the nine EHEN projects, including EXIMIOUS.

Our partner in the spotlight series continues, and we’re glad to present the Norwegian Institute of Public Health (NIPH). In EXIMIOUS, the team at NIPH makes use of CyTOF to identify immune-cell signatures.

More than 70 participants joined the second EXIMIOUS Symposium. Did you miss it? Read about it here and watch the full recording.